ホーム › 非小細胞肺癌 › ニューヨーク › New Rochelle
New Rochelle、NYにおける非小細胞肺癌の臨床試験
New Rochelleとその周辺地域（約30マイル以内）の拠点で、非小細胞肺癌に関する18件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
被験者募集中第3相
- The Cancer Institute at Saint Francis Hospital, East Hills · 11マイル先
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
被験者募集中第2相
- Memorial Sloan Kettering Westchester, Harrison · 5マイル先
A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer
被験者募集中第1相
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison · 5マイル先
Using Urine Samples to Identify Lung Cancer
被験者募集中観察研究健康なボランティア歓迎
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison · 5マイル先
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
被験者募集中第2相
- Memorial Sloan Kettering Westchester (Limited protocol activities), Harrison · 5マイル先
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
被験者募集中
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison · 5マイル先
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
被験者募集中第3相
- Memorial Sloan Kettering Westchester, Harrison · 5マイル先
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
被験者募集中第2相
- Memorial Sloan Kettering Westchester, Harrison · 5マイル先
A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung Cancer
被験者募集中第1/2相
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison · 5マイル先
Extracellular Vesicles and Particles (EVP) as Biomarkers of Recurrence in Non-Small Cell Lung Cancer
被験者募集中観察研究
- Memorial Sloan Kettering Westchester (Consent Only), Harrison · 5マイル先
A Study of Ivonescimab in People With Non-Small Cell Lung Cancer
被験者募集中第1/2相
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison · 5マイル先
A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)
被験者募集中第2相
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison · 5マイル先
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
被験者募集中第2相
- Memorial Sloan Kettering Westchester, Harrison · 5マイル先
A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer
被験者募集中第1/2相
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison · 5マイル先
Using E-Nose Technology to Track Treatment Response in People With Non-Small Cell Lung Cancer
被験者募集中第2相
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison · 5マイル先
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
被験者募集中第2相
- Memorial Sloan Kettering Westchester, Harrison · 5マイル先
A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer
被験者募集中第2相
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison · 5マイル先
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, Manhasset · 9マイル先
他の都市における非小細胞肺癌の試験
- Houston, TX145件の研究
- New York City, NY121件の研究
- Arlington, VA104件の研究
- Nashville, TN97件の研究
- Boston, MA90件の研究
- Los Angeles, CA87件の研究
- St. Louis, MO73件の研究
- Chicago, IL61件の研究
- Baltimore, MD60件の研究
- San Antonio, TX59件の研究
- Columbus, OH57件の研究
- Washington, DC55件の研究
New Rochelleにおける他の研究
- 乳がん38件の研究
- 前立腺がん16件の研究
- 多発性骨髄腫14件の研究
- 急性骨髄性白血病13件の研究
- 膀胱癌11件の研究
- 肺がん11件の研究
- 子宮内膜がん11件の研究
- 転移性癌10件の研究
- がん（全種類）10件の研究
- 卵巣がん9件の研究
- 心血管疾患8件の研究
- 膵臓がん8件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。